Summary:
Houston Endoscopy & Research Center is conducting a Multicenter, Double-blind, Placebo- and Active-Controlled Parallel-Group Evaluation of the Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder
*Study drug and study related medical care at no cost. Health insurance is not necessary to participate.
*Compensation for time and travel may be provided for those who qualify.
Qualified Participants Must:
• Be between 7 and 17 years of age
•
Have major depressive disorder, also called depression (feelings of sadness that have lasted for several weeks)